Gesco SE
XMUN:GSC1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nanjing Sinolife United Co Ltd
HKEX:3332
|
CN |
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
Gesco SE
Capital Expenditures
Gesco SE
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gesco SE
XMUN:GSC1
|
Capital Expenditures
-€11.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
S
|
Stabilus SE
XMUN:STM
|
Capital Expenditures
-€84.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-4%
|
|
Gesco SE
Glance View
GESCO SE is an investment holding company, which engages in acquiring small and medium enterprises. The company is headquartered in Wuppertal, Nordrhein-Westfalen and currently employs 1,904 full-time employees. The firm focuses on production process technology, resource technology, health and infrastructure technology, as well as mobility technology, and operates as a long-term investor. The company manages takeovers both through management buy-outs (MBOs) and management buy-ins (MBI), and also through group spin-offs. The firm operates in Germany and its subsidiaries include, among others, Astroplast Kunststofftechnick Gmbh & Co KG, Franz Funke Zerspanungstechnik GmbH & Co KG, Doemer GmbH & Co KG Stanz- und Umformtechnologie, Doerrenberg Edelstahl GmbH, MAE Group, SVT GmbH, Frank Group and Setter Group.
See Also
What is Gesco SE's Capital Expenditures?
Capital Expenditures
-11.9m
EUR
Based on the financial report for Sep 30, 2025, Gesco SE's Capital Expenditures amounts to -11.9m EUR.
What is Gesco SE's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
8%
Over the last year, the Capital Expenditures growth was -1%. The average annual Capital Expenditures growth rates for Gesco SE have been -8% over the past three years , 1% over the past five years , and 8% over the past ten years .
